QURE
Price:
$17.34
Market Cap:
$845.21M
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzhe...[Read more]
Industry
Biotechnology
IPO Date
2014-02-05
Stock Exchange
NASDAQ
Ticker
QURE
According to uniQure N.V.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of uniQure N.V. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), QURE's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of uniQure N.V. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of uniQure N.V. (QURE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
uniQure N.V.’s Dividend Yield is less than Rocket Pharmaceuticals, Inc. (0%), less than Rhythm Pharmaceuticals, Inc. (0%), less than Solid Biosciences Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Vaxcyte, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Merus N.V. (0%), less than Sutro Biopharma, Inc. (0%), less than Kiniksa Pharmaceuticals, Ltd. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Structure Therapeutics Inc. (0%), less than Karuna Therapeutics, Inc. (0%), less than Phathom Pharmaceuticals, Inc. (0%), less than REGENXBIO Inc. (0%), less than Replimune Group, Inc. (0%), less than Avidity Biosciences, Inc. (0%), less than Protagonist Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $1.26B | |
0% | $3.41B | |
0% | $166.21M | |
0% | $480.64M | |
0% | $490.95M | |
0% | $277.96M | |
0% | $107.54M | |
0% | $186.30M | |
0% | $102.82M | |
0% | $10.62B | |
0% | $243.74M | |
0% | $1.11B | |
0% | $2.91B | |
0% | $157.08M | |
0% | $1.44B | |
0% | $1.27B | |
0% | $1.64B | |
0% | $12.60B | |
0% | $498.81M | |
0% | $370.10M | |
0% | $945.15M | |
0% | $3.73B | |
0% | $2.35B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like uniQure N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like uniQure N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is uniQure N.V.'s Dividend Yield?
How is the Dividend Yield calculated for uniQure N.V. (QURE)?
What is the highest Dividend Yield for uniQure N.V. (QURE)?
What is the 3-year average Dividend Yield for uniQure N.V. (QURE)?
What is the 5-year average Dividend Yield for uniQure N.V. (QURE)?
How does the current Dividend Yield for uniQure N.V. (QURE) compare to its historical average?